AngioSoma, Inc. to upgrade its OmniCath Patents into OmniCath 2 Atherectomy Catheter

MONTGOMERY, TEXAS (Business Wire, November 4, 2016 at 9:36 AM CST) – AngioSoma, Inc. today announces that it was filing new improvements to its US Patent No. 5,728,129 and five predecessor patents 4,850,957; 4,994,067; 5,087,265; and 5,695,519; all of which will be used as “prior art” to the its newest catheter, the OmniCath® II.  With Read more about AngioSoma, Inc. to upgrade its OmniCath Patents into OmniCath 2 Atherectomy Catheter[…]